Go Pro

ALT5 Sigma (AIFC) Financials

ALT5 Sigma logo
$0.55 -0.02 (-4.04%)
As of 07/16/2026 04:00 PM Eastern
Annual Income Statements for ALT5 Sigma

Annual Income Statements for ALT5 Sigma

This table shows ALT5 Sigma's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025
Period end date 1/3/2015 1/2/2016 12/31/2016 12/30/2017 12/29/2018 12/28/2019 1/2/2021 12/31/2022 12/30/2023 12/28/2024 12/27/2025
Net Income / (Loss) Attributable to Common Shareholders
0.77 -2.72 -1.45 0.12 -5.61 -12 -9.35 11 -7.81 -15 -343
Consolidated Net Income / (Loss)
0.80 -3.93 -0.47 5.40 -5.61 -12 -8.50 11 -7.81 -15 -343
Net Income / (Loss) Continuing Operations
2.79 -1.35 -0.47 5.40 -5.61 -12 -9.35 8.02 -17 -17 -341
Total Pre-Tax Income
1.51 -5.65 -0.04 4.07 -6.34 -15 -8.93 1.40 -18 -17 -428
Total Operating Income
2.55 -4.10 1.12 -0.23 -6.10 -12 -9.00 -3.15 -20 -14 -23
Total Gross Profit
33 25 12 13 11 7.79 8.83 0.00 0.00 11 10
Total Revenue
131 112 40 42 37 35 34 0.00 0.00 24 25
Operating Revenue
131 112 40 42 37 35 34 0.00 0.00 24 25
Total Cost of Revenue
98 86 28 28 26 27 25 0.00 0.00 12 15
Operating Cost of Revenue
98 86 28 28 26 27 25 0.00 0.00 12 15
Total Operating Expenses
30 30 11 13 17 20 18 3.15 20 25 33
Selling, General & Admin Expense
30 30 11 13 17 20 18 3.15 4.75 25 33
Total Other Income / (Expense), net
0.95 1.04 -1.16 4.30 -0.24 -2.73 0.07 4.55 2.32 -3.08 -405
Interest & Investment Income
- - - - - - - - 2.25 -2.32 -3.87
Other Income / (Expense), net
-0.05 -0.25 0.01 5.19 0.43 -1.25 0.58 4.08 0.07 -0.76 -402
Income Tax Expense
0.71 -1.71 0.43 -1.33 -0.73 -3.20 0.43 -6.62 -0.43 -0.32 -87
Net Income / (Loss) Discontinued Operations
- - - - - - - 2.97 9.28 1.47 -3.02
Basic Earnings per Share
$0.14 ($0.47) ($0.24) $0.02 ($3.75) ($6.78) ($4.59) $3.49 ($1.95) ($1.36) ($5.91)
Weighted Average Basic Shares Outstanding
5.68M 5.83M 6.05M 6.71M 1.49M 1.76M 1.85M 3.15M 4.01M 11.20M 58.30M
Diluted Earnings per Share
$0.13 ($0.47) ($0.24) $0.02 ($3.75) ($6.78) ($4.59) $3.49 ($1.95) ($1.36) ($5.91)
Weighted Average Diluted Shares Outstanding
5.78M 5.83M 6.66M 5.90M 1.49M 1.76M 1.85M 3.15M 4.44M 11.20M 58.30M

Quarterly Income Statements for ALT5 Sigma

This table shows ALT5 Sigma's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 12/27/2025 3/28/2026
Net Income / (Loss) Attributable to Common Shareholders
-0.21 -18 -2.14 0.59 -0.82 -13 -1.94 -9.12 49 -380 -271
Consolidated Net Income / (Loss)
-0.21 -18 -2.14 0.59 -0.82 -13 -2.39 -9.12 49 -380 -271
Net Income / (Loss) Continuing Operations
-0.24 -16 -2.14 0.97 -0.44 -15 -1.91 -5.50 47 -380 -271
Total Pre-Tax Income
-0.27 -16 -2.22 -1.78 -0.85 -12 -1.69 -5.93 59 -478 -356
Total Operating Income
-0.76 -17 -1.81 -2.43 -0.73 -8.87 -1.95 -2.10 -17 -2.05 -2.74
Total Gross Profit
0.00 - 0.00 1.10 2.36 7.84 1.93 2.78 2.62 2.20 3.57
Total Revenue
0.00 - 0.00 2.17 4.94 17 4.85 6.38 7.58 5.37 4.71
Operating Revenue
0.00 - 0.00 2.17 4.94 17 4.85 6.38 7.58 5.37 4.71
Total Cost of Revenue
0.00 - 0.00 1.07 2.58 8.83 2.92 3.60 4.95 3.17 1.14
Operating Cost of Revenue
0.00 - 0.00 1.07 2.58 8.83 2.92 3.60 4.95 3.17 1.14
Total Operating Expenses
0.76 17 1.81 3.53 3.09 17 3.87 4.87 19 4.25 6.32
Selling, General & Admin Expense
0.76 1.82 1.81 3.53 3.09 17 3.87 4.87 19 4.25 6.32
Total Other Income / (Expense), net
0.50 0.49 -0.41 0.65 -0.12 -3.20 0.26 -3.84 75 -476 -354
Interest & Investment Income
0.76 - -0.25 0.00 0.25 -2.32 -0.72 -0.55 -0.84 -1.76 -0.51
Other Income / (Expense), net
-0.26 -0.16 -0.16 0.65 -0.37 -0.88 0.98 -3.29 76 -475 -353
Income Tax Expense
-0.03 -0.16 -0.08 -2.75 -0.42 2.92 -0.23 -0.43 12 -99 -85
Net Income / (Loss) Discontinued Operations
0.03 -1.54 - -0.38 -0.39 - -0.48 -3.61 2.31 - -0.18
Basic Earnings per Share
($0.05) ($5.08) ($0.34) $0.07 ($0.06) ($1.03) ($0.15) ($0.49) $0.67 ($5.91) ($2.14)
Weighted Average Basic Shares Outstanding
4.20M 4.01M 6.31M 8.40M 12.81M 11.20M 15.55M 18.55M 72.89M 58.30M 126.82M
Diluted Earnings per Share
($0.05) ($5.08) ($0.34) $0.07 ($0.06) ($1.03) ($0.15) ($0.49) $0.29 ($5.53) ($2.14)
Weighted Average Diluted Shares Outstanding
4.20M 4.44M 6.31M 8.40M 12.81M 11.20M 15.55M 18.55M 168.66M 58.30M 126.82M
Weighted Average Basic & Diluted Shares Outstanding
- 0.00 8.98M 12.77M 14.07M 16.08M 17.45M 122.61M - 0.00 139.84M

Annual Cash Flow Statements for ALT5 Sigma

This table details how cash moves in and out of ALT5 Sigma's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025
Period end date 1/3/2015 1/2/2016 12/31/2016 12/30/2017 12/29/2018 12/28/2019 1/2/2021 12/31/2022 12/30/2023 12/28/2024 12/27/2025
Net Change in Cash & Equivalents
1.58 -1.55 -1.00 2.35 -2.14 -0.70 -0.10 -0.59 -0.11 7.17 -0.96
Net Cash From Operating Activities
3.60 -3.41 2.66 1.23 4.15 -3.51 -0.62 -3.06 1.46 1.78 -7.16
Net Cash From Continuing Operating Activities
3.60 -3.41 2.78 -2.26 4.15 -3.51 -0.62 -0.56 -0.86 1.78 -7.16
Net Income / (Loss) Continuing Operations
0.80 -3.93 -0.47 5.40 -5.61 -12 -8.50 8.02 -17 -8.30 -341
Consolidated Net Income / (Loss)
0.80 -3.93 -1.77 -0.38 -5.61 -12 -8.50 8.02 -17 -8.30 -341
Depreciation Expense
1.36 1.27 0.96 2.15 4.00 4.08 4.12 0.00 1.45 1.32 3.34
Amortization Expense
0.10 0.11 0.19 0.25 0.59 0.31 0.03 - 0.00 0.03 0.30
Non-Cash Adjustments To Reconcile Net Income
-0.02 0.31 0.28 -5.10 0.62 2.93 0.11 -0.39 15 5.82 413
Changes in Operating Assets and Liabilities, net
1.36 -1.17 1.82 -4.96 4.55 1.14 3.62 -8.19 -0.65 2.91 -82
Net Cash From Discontinued Operating Activities
- - -0.12 3.49 - - - -2.50 2.32 0.00 0.00
Net Cash From Investing Activities
-0.30 -0.95 -0.41 7.33 -0.17 0.35 -0.83 -1.51 -0.16 5.85 -707
Net Cash From Continuing Investing Activities
-0.30 -0.95 -0.41 7.33 -0.17 0.35 -0.83 0.00 0.00 5.85 -707
Purchase of Property, Plant & Equipment
-0.82 -0.40 -0.38 -0.02 -0.40 -0.21 -0.51 - - 0.00 -0.01
Acquisitions
- - 0.00 -0.20 - -0.29 -0.33 - 0.00 5.85 0.00
Divestitures
- - - - - - - - - 0.00 0.12
Other Investing Activities, net
0.50 -0.55 -0.04 0.77 - - - - - 0.00 -707
Net Cash From Discontinued Investing Activities
- - 0.00 0.00 - - - -1.51 -0.16 0.00 0.00
Net Cash From Financing Activities
-1.52 3.01 -3.22 -6.27 -6.11 2.46 1.40 3.98 -1.44 6.09 717
Net Cash From Continuing Financing Activities
-1.52 3.01 -3.22 -6.27 -6.11 2.46 1.40 -0.01 0.78 6.09 717
Repayment of Debt
-1.55 -0.76 -3.42 -13 -6.67 -0.51 -2.07 -0.01 -0.27 -3.10 -4.69
Issuance of Debt
- 3.76 0.20 6.84 0.56 2.97 3.47 - 0.00 7.84 4.03
Issuance of Common Equity
0.02 0.02 - - - - 0.00 0.00 0.79 0.00 750
Other Financing Activities, net
0.00 -0.01 - - - - 0.00 0.00 0.26 1.35 -33
Net Cash From Discontinued Financing Activities
- - - 0.00 - - - 3.99 -2.21 0.00 0.00
Effect of Exchange Rate Changes
-0.20 -0.21 -0.02 0.06 - - -0.06 -0.00 0.02 -6.55 -3.99
Cash Interest Paid
0.89 0.97 1.05 0.78 0.53 0.13 0.13 0.41 0.13 0.30 1.39
Cash Income Taxes Paid
1.66 -0.69 -0.87 0.05 0.20 0.26 0.03 0.11 0.00 0.02 0.00

Quarterly Cash Flow Statements for ALT5 Sigma

This table details how cash moves in and out of ALT5 Sigma's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 12/27/2025 3/28/2026
Net Change in Cash & Equivalents
0.24 -0.41 0.06 5.70 5.90 -1.49 3.75 -1.25 -9.76 6.42 4.30
Net Cash From Operating Activities
-0.44 -0.41 -0.54 0.08 4.19 -1.95 -1.42 -5.18 -8.74 8.31 -12
Net Cash From Continuing Operating Activities
-0.44 -0.41 -0.54 0.08 4.19 -1.95 -1.42 -5.18 -8.74 8.31 -12
Net Income / (Loss) Continuing Operations
-0.24 -16 -2.14 1.49 -0.43 -3.87 -2.39 -4.96 47 -380 -271
Consolidated Net Income / (Loss)
-0.24 -16 -2.14 - - -3.87 -2.39 - - -380 -271
Depreciation Expense
0.36 0.36 0.64 -0.46 0.54 1.08 1.21 0.35 0.90 0.88 0.89
Amortization Expense
- - 0.00 - 0.01 0.02 0.04 0.12 0.12 0.03 0.13
Non-Cash Adjustments To Reconcile Net Income
-0.23 16 1.14 -0.92 4.06 -0.50 2.82 -0.33 -70 480 345
Changes in Operating Assets and Liabilities, net
-0.33 -0.43 -0.17 -0.03 0.02 1.31 -3.10 -0.36 13 -92 -87
Net Cash From Discontinued Operating Activities
- -0.00 - - - - 0.00 - - - 0.00
Net Cash From Investing Activities
- 0.00 0.00 5.85 - - 0.00 0.12 -711 4.70 0.00
Net Cash From Continuing Investing Activities
- - 0.00 5.85 - - 0.00 0.12 -711 4.70 0.00
Net Cash From Discontinued Investing Activities
- 0.00 - - - - 0.00 - - - 0.00
Net Cash From Financing Activities
0.68 - 0.60 0.58 0.90 4.02 1.54 2.16 716 -2.59 8.52
Net Cash From Continuing Financing Activities
0.68 - 0.60 0.58 0.90 4.02 1.54 2.16 716 -2.59 8.52
Repayment of Debt
- - 0.00 -0.25 -2.23 -0.62 -0.13 -0.08 -1.95 -2.52 -1.48
Issuance of Debt
- - 0.00 0.58 3.13 4.14 1.60 2.24 0.19 - 15
Other Financing Activities, net
- - 0.00 - - 0.50 0.08 0.00 -33 -0.07 -5.00
Net Cash From Discontinued Financing Activities
- - - - - - 0.00 - - - 0.00
Effect of Exchange Rate Changes
- - 0.00 -0.81 - -3.56 3.63 1.65 - - 8.08
Cash Interest Paid
- 0.02 0.00 - - 0.30 0.39 0.24 -0.63 1.39 0.27

Annual Balance Sheets for ALT5 Sigma

This table presents ALT5 Sigma's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025
Period end date 1/3/2015 1/2/2016 12/31/2016 12/30/2017 12/29/2018 12/28/2019 1/2/2021 12/31/2022 12/30/2023 12/28/2024 12/27/2025
Total Assets
47 47 42 47 35 29 24 47 18 76 1,219
Total Current Assets
34 33 29 21 8.94 8.84 6.94 9.17 0.35 34 29
Cash & Equivalents
3.52 1.97 0.97 3.31 1.20 0.48 0.38 0.06 0.01 7.18 6.22
Short-Term Investments
- - - - - - - - - - 0.00
Accounts Receivable
11 12 11 10 5.80 6.58 3.60 0.11 0.27 0.33 2.29
Prepaid Expenses
1.10 1.35 0.76 0.51 1.04 0.36 1.14 0.39 0.08 0.88 2.37
Other Current Assets
- - - 6.50 - - - - 0.00 24 18
Other Current Nonoperating Assets
- - - - - - - 8.61 - 2.20 0.21
Plant, Property, & Equipment, net
12 11 10 0.54 0.21 0.32 0.73 0.00 0.00 0.00 0.03
Total Noncurrent Assets
0.72 3.15 3.20 25 26 20 17 38 18 41 1,190
Goodwill
- - - - - - - - 0.00 3.88 12
Intangible Assets
- - 0.06 25 21 18 14 19 18 19 23
Noncurrent Deferred & Refundable Income Taxes
0.01 1.98 2.08 - - - - - - 0.00 84
Other Noncurrent Operating Assets
0.71 1.16 1.06 0.52 0.66 2.17 2.69 9.00 0.01 0.12 1,055
Other Noncurrent Nonoperating Assets
- - - - - - - - - 19 16
Total Liabilities & Shareholders' Equity
47 47 42 47 35 29 24 47 18 76 1,219
Total Liabilities
31 35 31 21 13 19 22 30 7.29 56 60
Total Current Liabilities
25 30 27 16 9.68 18 21 24 5.91 41 51
Short-Term Debt
10 14 12 5.88 0.68 2.75 1.14 0.27 0.00 1.38 6.51
Accounts Payable
6.38 7.02 6.14 5.32 4.29 8.30 9.59 3.28 2.27 3.23 5.10
Accrued Expenses
8.13 8.93 8.89 - - - - - 3.63 2.52 8.54
Other Current Liabilities
- - - - 0.00 1.08 4.10 - 0.00 31 29
Other Current Nonoperating Liabilities
- - - - - - - 20 - 2.85 2.55
Total Noncurrent Liabilities
6.54 4.93 3.19 4.89 3.75 1.12 1.39 6.00 1.38 15 8.85
Long-Term Debt
5.12 4.57 2.83 - - - 0.00 0.00 0.71 12 8.75
Other Noncurrent Operating Liabilities
0.37 0.36 0.36 0.31 0.20 - 0.00 0.05 0.03 0.11 0.11
Commitments & Contingencies
0.00 0.00 - - 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
- - - - - - - 15 15 3.86 3.86
Total Equity & Noncontrolling Interests
16 12 11 26 22 10 2.37 2.31 -3.31 16 1,155
Total Preferred & Common Equity
14 11 11 26 22 10 2.37 2.31 -3.31 12 1,152
Preferred Stock
- - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 10 9.44
Total Common Equity
14 11 11 26 22 10 2.37 2.31 -3.31 2.35 1,142
Common Stock
21 21 22 38 39 39 40 46 47 63 1,551
Retained Earnings
-6.86 -9.58 -11 -11 -17 -28 -37 -43 -51 -58 -403
Accumulated Other Comprehensive Income / (Loss)
-0.68 -0.57 -0.57 -0.49 -0.53 -0.53 -0.59 -0.62 0.00 -2.32 -6.31
Noncontrolling Interest
1.94 0.72 0.41 - - - - - 0.00 3.65 3.50

Quarterly Balance Sheets for ALT5 Sigma

This table presents ALT5 Sigma's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2023 3/30/2024 6/29/2024 9/28/2024 3/29/2025 6/28/2025 9/27/2025 3/28/2026
Total Assets
34 19 75 75 78 95 1,640 960
Total Current Assets
0.52 1.19 31 32 32 34 45 32
Cash & Equivalents
0.41 0.06 5.76 8.67 11 9.56 7.32 11
Short-Term Investments
- - - - - - - 5.00
Accounts Receivable
0.02 0.33 0.98 0.90 5.17 5.85 1.00 1.35
Prepaid Expenses
0.09 0.80 1.66 1.44 1.27 3.71 2.99 2.22
Other Current Assets
- - 22 21 15 14 33 13
Other Current Nonoperating Assets
0.00 - - - - 0.21 0.21 0.19
Plant, Property, & Equipment, net
0.00 0.00 1.17 1.17 1.17 0.02 0.03 0.03
Total Noncurrent Assets
34 17 43 42 45 61 1,595 927
Goodwill
- - 7.72 7.72 12 20 20 12
Intangible Assets
18 17 35 34 33 25 24 22
Noncurrent Deferred & Refundable Income Taxes
- - - - - - - 171
Other Noncurrent Operating Assets
0.36 0.00 0.19 0.12 0.12 0.11 1,534 706
Other Noncurrent Nonoperating Assets
- - - - - 16 17 16
Total Liabilities & Shareholders' Equity
34 19 75 75 78 95 1,640 960
Total Liabilities
5.48 11 49 51 49 62 80 63
Total Current Liabilities
2.50 8.08 43 42 38 38 56 39
Short-Term Debt
0.00 0.60 5.94 3.94 4.72 5.34 9.03 4.94
Accounts Payable
2.50 4.58 2.94 2.88 2.90 4.17 4.01 3.26
Accrued Expenses
- - 2.44 3.80 2.86 2.66 8.78 9.10
Other Current Liabilities
- 2.90 31 32 28 24 32 20
Other Current Nonoperating Liabilities
0.00 - - - - 2.51 2.72 1.58
Total Noncurrent Liabilities
2.98 2.87 6.10 8.48 11 23 24 24
Long-Term Debt
- 0.50 4.38 7.22 9.42 17 8.66 23
Other Noncurrent Operating Liabilities
0.04 1.81 0.13 0.09 0.17 0.16 0.12 0.09
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest
15 3.90 3.90 3.90 3.90 3.90 3.90 3.86
Total Equity & Noncontrolling Interests
14 3.77 23 20 25 29 1,556 893
Total Preferred & Common Equity
14 3.77 23 20 22 26 1,553 890
Preferred Stock
0.00 7.99 17 17 18 17 17 9.44
Total Common Equity
14 -4.22 6.39 3.68 3.96 8.69 1,536 880
Common Stock
47 49 59 60 62 75 1,550 1,553
Retained Earnings
-33 -53 -52 -53 -60 -69 -20 -674
Accumulated Other Comprehensive Income / (Loss)
0.00 - -0.81 -3.00 1.32 2.97 5.20 1.77
Noncontrolling Interest
- - - - 3.50 3.20 3.20 3.50

Annual Metrics And Ratios for ALT5 Sigma

This table displays calculated financial ratios and metrics derived from ALT5 Sigma's official financial filings.

Metric 2014 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025
Period end date 1/3/2015 1/2/2016 12/31/2016 12/30/2017 12/29/2018 12/28/2019 1/2/2021 12/31/2022 12/30/2023 12/28/2024 12/27/2025
DEI Shares Outstanding
11,589,136.00 5,900,818.00 6,655,365.00 13,750,730.00 16,945,302.00 1,917,779.00 1,829,982.00 6,300,460.00 4,957,647.00 14,069,469.00 122,609,376.00
DEI Adjusted Shares Outstanding
2,317,827.00 1,180,164.00 1,331,073.00 2,750,146.00 3,389,060.00 1,917,779.00 1,829,982.00 6,300,460.00 4,957,647.00 14,069,469.00 122,609,376.00
DEI Earnings Per Adjusted Shares Outstanding
0.33 -2.30 -1.09 0.04 -1.65 -6.24 -5.11 1.74 -1.58 -1.08 -2.80
Growth Metrics
- - - - - - - - - - -
Revenue Growth
2.39% -14.58% -63.82% 2.68% -11.43% -4.61% -3.50% 0.00% 0.00% 0.00% 4.48%
EBITDA Growth
-17.52% -175.10% 176.32% 223.99% -114.67% -760.93% 54.05% 0.00% -2,063.77% 27.65% -3,073.79%
EBIT Growth
-24.23% -273.81% 125.91% 339.81% -214.23% -141.42% 38.45% 0.00% -2,223.95% 26.15% -2,805.77%
NOPAT Growth
-76.52% -313.76% 127.27% -139.13% -1,292.27% -103.89% 27.63% 0.00% 23.04% 30.23% -65.04%
Net Income Growth
-77.04% -594.59% 88.15% 1,258.15% -203.91% -113.34% 28.97% 0.00% -171.07% -93.75% -2,167.49%
EPS Growth
-76.36% -461.54% 48.94% 1,258.15% -203.91% -80.80% 32.30% 0.00% -155.87% 30.26% -334.56%
Operating Cash Flow Growth
106.61% -194.83% 178.00% -53.89% 238.09% -184.68% 82.42% 0.00% 147.86% 21.46% -502.76%
Free Cash Flow Firm Growth
-45.37% -241.67% 198.08% -193.73% 195.23% -131.18% 346.51% 0.00% 0.00% -170.33% -18,823.80%
Invested Capital Growth
-4.95% 3.85% -10.76% 12.98% -26.77% -36.17% -66.43% 0.00% -66.07% -30.55% 14,209.08%
Revenue Q/Q Growth
0.09% -4.89% -60.90% 521.92% 44.75% 6.60% -6.28% 0.00% 0.00% 234.37% -0.20%
EBITDA Q/Q Growth
-11.95% -58.35% 476.78% -20.17% 18.98% -130.09% 46.27% 0.00% -349.29% 36.41% -876.06%
EBIT Q/Q Growth
-17.35% -32.14% 156.32% -36.67% 4.96% -66.05% 31.58% 0.00% -341.78% 33.42% -969.95%
NOPAT Q/Q Growth
-69.71% -31.16% 153.72% -116.17% 0.70% -35.90% 18.85% 0.00% -313.20% 36.76% 6.97%
Net Income Q/Q Growth
-71.61% -18.97% 84.27% 8.66% -123.96% -75.40% 30.01% 0.00% -160.64% 25.01% -1,136.32%
EPS Q/Q Growth
-69.05% -11.90% 36.84% 8.66% -123.96% -71.21% 29.28% 0.00% -144.93% 74.86% -868.85%
Operating Cash Flow Q/Q Growth
196.62% -57.53% 10.75% -5.91% 89.96% -24.60% 32.12% 0.00% 21.31% -46.48% 58.91%
Free Cash Flow Firm Q/Q Growth
192.49% -1,303.80% 73.37% 50.06% -45.70% 73.55% 8.75% 100.00% 134.54% 54.59% 24.84%
Invested Capital Q/Q Growth
-9.97% 1.89% 4.68% -14.00% -7.70% -34.35% -56.18% 431.51% -59.05% -69.64% -25.80%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
25.06% 22.75% 30.55% 31.64% 30.04% 22.18% 26.06% 0.00% 0.00% 47.52% 41.01%
EBITDA Margin
3.03% -2.66% 5.62% 17.72% -2.94% -26.49% -12.61% 0.00% 0.00% -55.76% -1,693.71%
Operating Margin
1.95% -3.67% 2.77% -0.56% -16.57% -35.42% -26.56% 0.00% 0.00% -58.24% -91.99%
EBIT Margin
1.91% -3.89% 2.79% 11.94% -15.40% -38.98% -24.86% 0.00% 0.00% -61.43% -1,708.37%
Profit (Net Income) Margin
0.61% -3.52% -1.15% 12.99% -15.24% -34.09% -25.09% 0.00% 0.00% -63.67% -1,381.67%
Tax Burden Percent
52.68% 69.64% 1,165.00% 132.70% 88.52% 78.91% 95.22% 785.70% 44.58% 89.45% 80.15%
Interest Burden Percent
60.24% 129.67% -3.55% 81.98% 111.79% 110.82% 105.99% 150.27% 88.62% 115.87% 100.91%
Effective Tax Rate
47.32% 0.00% 0.00% -32.70% 0.00% 0.00% 0.00% -473.27% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
4.76% -10.25% 2.90% -1.13% -17.11% -50.37% -70.04% 0.00% 0.00% -98.46% -2.75%
ROIC Less NNEP Spread (ROIC-NNEP)
0.58% -17.68% -5.21% 66.58% -148.23% -301.12% -153.48% 0.00% 0.00% -3.54% 3,966.33%
Return on Net Nonoperating Assets (RNNOA)
0.51% -18.27% -6.91% 29.95% -6.33% -24.52% -63.71% 0.00% 0.00% 1.30% -55.46%
Return on Equity (ROE)
5.27% -28.51% -4.01% 28.82% -23.44% -74.89% -133.75% 65.36% -55.76% -97.16% -58.21%
Cash Return on Invested Capital (CROIC)
9.84% -14.03% 14.27% -13.32% 13.80% -6.21% 29.44% 0.00% 38.09% -62.41% -199.98%
Operating Return on Assets (OROA)
5.37% -9.28% 2.54% 11.18% -13.83% -42.70% -31.55% 0.00% 0.00% -31.00% -65.53%
Return on Assets (ROA)
1.71% -8.38% -1.05% 12.16% -13.69% -37.34% -31.84% 0.00% 0.00% -32.13% -53.00%
Return on Common Equity (ROCE)
4.60% -25.77% -3.81% 28.51% -23.44% -74.89% -133.75% 8.97% 1.99% 2.98% -56.51%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
1.34 -2.87 0.78 -0.31 -4.27 -8.70 -6.30 -18 -14 -9.69 -16
NOPAT Margin
1.03% -2.57% 1.94% -0.74% -11.60% -24.79% -18.59% 0.00% 0.00% -40.77% -64.39%
Net Nonoperating Expense Percent (NNEP)
4.18% 7.43% 8.11% -67.71% 131.13% 250.75% 83.44% -166.65% -68.15% -94.92% -3,969.08%
Return On Investment Capital (ROIC_SIMPLE)
4.33% -9.41% 2.96% -0.95% -19.15% -62.40% -128.57% -699.43% 534.11% -32.93% -1.37%
Cost of Revenue to Revenue
74.94% 77.25% 69.45% 68.36% 69.96% 77.82% 73.94% 0.00% 0.00% 52.48% 58.99%
SG&A Expenses to Revenue
23.11% 26.42% 27.78% 32.20% 46.61% 57.60% 52.63% 0.00% 0.00% 105.76% 133.01%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
23.11% 26.42% 27.78% 32.20% 46.61% 57.60% 52.63% 0.00% 0.00% 105.76% 133.01%
Earnings before Interest and Taxes (EBIT)
2.51 -4.35 1.13 4.96 -5.67 -14 -8.42 0.93 -20 -15 -424
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
3.96 -2.98 2.27 7.36 -1.08 -9.30 -4.27 0.93 -18 -13 -421
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.13 0.55 0.69 0.27 0.16 0.54 3.78 1.87 0.00 26.63 0.13
Price to Tangible Book Value (P/TBV)
1.13 0.55 0.69 4.70 16.00 0.00 0.00 0.00 0.00 0.00 0.13
Price to Revenue (P/Rev)
0.12 0.06 0.18 0.17 0.09 0.16 0.26 0.00 0.00 2.63 5.82
Price to Earnings (P/E)
20.01 0.00 0.00 60.60 0.00 0.00 0.00 0.39 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
5.00% 0.00% 0.00% 1.65% 0.00% 0.00% 0.00% 254.69% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
1.07 0.82 0.87 0.34 0.14 0.65 2.46 0.55 1.52 10.70 0.15
Enterprise Value to Revenue (EV/Rev)
0.22 0.21 0.55 0.23 0.08 0.25 0.33 0.00 0.00 3.63 6.86
Enterprise Value to EBITDA (EV/EBITDA)
7.40 0.00 9.75 1.32 0.00 0.00 0.00 20.07 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
11.71 0.00 19.63 1.96 0.00 0.00 0.00 20.11 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
21.82 0.00 28.27 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
8.16 0.00 8.33 7.92 0.71 0.00 0.00 0.00 12.08 48.60 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
10.57 0.00 5.74 0.00 0.86 0.00 4.19 0.00 2.02 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.00 1.54 1.36 0.22 0.03 0.35 1.07 0.02 0.06 0.67 0.01
Long-Term Debt to Equity
0.33 0.38 0.25 0.00 0.00 0.08 0.59 0.00 0.06 0.60 0.01
Financial Leverage
0.87 1.03 1.32 0.45 0.04 0.08 0.42 1.04 0.64 -0.37 -0.01
Leverage Ratio
3.09 3.40 3.81 2.37 1.71 2.01 4.20 2.78 2.33 3.02 1.10
Compound Leverage Factor
1.86 4.41 -0.14 1.94 1.91 2.22 4.45 4.18 2.06 3.50 1.11
Debt to Total Capital
49.93% 60.56% 57.64% 18.30% 3.03% 25.84% 51.69% 1.60% 5.94% 40.05% 1.30%
Short-Term Debt to Total Capital
33.44% 45.58% 46.96% 18.30% 3.03% 19.74% 23.36% 1.60% 0.00% 4.13% 0.55%
Long-Term Debt to Total Capital
16.49% 14.98% 10.68% 0.00% 0.00% 6.10% 28.34% 0.00% 5.94% 35.92% 0.74%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 30.34% 0.80%
Noncontrolling Interests to Total Capital
6.24% 2.36% 1.53% 0.00% 0.00% 0.00% 0.00% 84.90% 121.84% 22.55% 0.63%
Common Equity to Total Capital
43.84% 37.08% 40.83% 81.70% 96.97% 74.16% 48.31% 13.50% -27.78% 7.06% 97.27%
Debt to EBITDA
3.91 -6.21 6.71 0.80 -0.63 -0.39 -0.59 0.29 -0.04 -1.01 -0.04
Net Debt to EBITDA
3.02 -5.55 6.29 0.35 0.48 -0.34 -0.50 -0.11 -0.02 -0.46 -0.02
Long-Term Debt to EBITDA
1.29 -1.54 1.24 0.00 0.00 -0.09 -0.32 0.00 -0.04 -0.90 -0.02
Debt to NOPAT
11.53 -6.44 19.47 -19.17 -0.16 -0.41 -0.40 -0.02 -0.05 -1.38 -0.95
Net Debt to NOPAT
8.91 -5.75 18.24 -8.36 0.12 -0.36 -0.34 0.01 -0.03 -0.64 -0.56
Long-Term Debt to NOPAT
3.81 -1.59 3.61 0.00 0.00 -0.10 -0.22 0.00 -0.05 -1.23 -0.55
Altman Z-Score
3.30 1.97 0.86 1.25 -0.01 -1.90 -2.30 -1.51 -7.50 -0.83 -0.17
Noncontrolling Interest Sharing Ratio
12.74% 9.63% 4.84% 1.08% 0.00% 0.00% 0.00% 86.28% 103.57% 103.07% 2.92%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.39 1.10 1.04 1.34 0.92 0.50 0.34 0.38 0.06 0.84 0.57
Quick Ratio
0.58 0.45 0.42 0.85 0.72 0.40 0.19 0.01 0.05 0.18 0.17
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
2.78 -3.93 3.86 -3.62 3.44 -1.07 2.65 0.00 8.73 -6.14 -1,163
Operating Cash Flow to CapEx
448.25% -858.69% 709.07% 0.00% 1,211.99% -1,655.66% -121.70% 0.00% 0.00% 0.00% -65,063.64%
Free Cash Flow to Firm to Interest Expense
2.79 -3.04 3.30 -4.04 5.15 -0.73 5.25 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
3.61 -2.64 2.28 1.37 6.21 -2.37 -1.22 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
2.80 -2.95 1.96 8.94 5.69 -2.51 -2.23 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
2.81 2.38 0.91 0.94 0.90 1.10 1.27 0.00 0.00 0.50 0.04
Accounts Receivable Turnover
11.27 9.95 3.67 4.04 4.65 5.67 6.65 0.00 0.00 79.78 18.95
Inventory Turnover
5.99 5.26 1.70 3.33 32.94 25.42 16.82 0.00 0.00 0.00 0.00
Fixed Asset Turnover
11.29 9.83 3.83 7.80 98.25 131.20 64.14 0.00 0.00 0.00 0.00
Accounts Payable Turnover
16.01 12.90 4.27 4.96 5.36 4.34 2.80 0.00 0.00 4.54 3.52
Days Sales Outstanding (DSO)
32.38 36.70 99.44 90.25 78.57 64.38 54.85 0.00 0.00 4.58 19.26
Days Inventory Outstanding (DIO)
60.95 69.39 214.48 109.59 11.08 14.36 21.70 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
22.80 28.31 85.48 73.66 68.11 84.13 130.40 0.00 0.00 80.48 103.78
Cash Conversion Cycle (CCC)
70.52 77.78 228.44 126.18 21.54 -5.38 -53.85 0.00 0.00 -75.91 -84.52
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
28 29 25 29 21 13 4.52 34 12 8.07 1,155
Invested Capital Turnover
4.64 3.99 1.50 1.53 1.47 2.03 3.77 0.00 0.00 2.42 0.04
Increase / (Decrease) in Invested Capital
-1.43 1.06 -3.07 3.31 -7.71 -7.63 -8.94 0.00 -23 -3.55 1,147
Enterprise Value (EV)
29 23 22 9.71 2.95 8.74 11 19 18 86 171
Market Capitalization
15 6.20 7.45 7.15 3.47 5.62 8.95 4.32 2.75 63 145
Book Value per Share
$2.35 $1.92 $1.62 $3.82 $3.14 $5.39 $1.29 $0.73 ($0.67) $0.17 $9.32
Tangible Book Value per Share
$2.35 $1.92 $1.61 $0.22 $0.03 ($3.84) ($6.35) ($5.39) ($4.27) ($1.44) $9.03
Total Capital
31 31 26 32 22 14 4.90 17 12 33 1,174
Total Debt
15 18 15 5.88 0.68 3.60 2.53 0.27 0.71 13 15
Total Long-Term Debt
5.12 4.57 2.83 0.00 0.00 0.85 1.39 0.00 0.71 12 8.75
Net Debt
12 17 14 2.56 -0.52 3.12 2.15 -0.10 0.42 6.16 9.03
Capital Expenditures (CapEx)
0.80 0.40 0.38 -6.76 0.34 0.21 0.51 0.00 0.00 0.00 0.01
Debt-free, Cash-free Net Working Capital (DFCFNWC)
16 15 13 7.92 -1.27 -6.46 -13 -15 -5.56 -12 -22
Debt-free Net Working Capital (DFNWC)
20 17 14 11 -0.07 -5.98 -13 -14 -5.56 -5.16 -15
Net Working Capital (NWC)
9.59 2.84 1.09 5.36 -0.75 -8.73 -14 -15 -5.56 -6.54 -22
Net Nonoperating Expense (NNE)
0.55 1.06 1.25 -5.70 1.34 3.26 2.20 -29 -6.08 5.44 327
Net Nonoperating Obligations (NNO)
12 17 14 2.56 -0.52 3.12 2.15 17 0.42 -12 -4.60
Total Depreciation and Amortization (D&A)
1.46 1.38 1.14 2.40 4.59 4.38 4.15 0.00 1.45 1.35 3.64
Debt-free, Cash-free Net Working Capital to Revenue
12.56% 13.23% 31.01% 19.06% -3.44% -18.41% -38.06% 0.00% 0.00% -51.91% -87.15%
Debt-free Net Working Capital to Revenue
15.25% 14.99% 33.40% 27.04% -0.20% -17.04% -36.94% 0.00% 0.00% -21.72% -62.10%
Net Working Capital to Revenue
7.32% 2.54% 2.69% 12.89% -2.03% -24.89% -40.32% 0.00% 0.00% -27.50% -88.30%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.70 ($2.35) ($1.20) $0.10 ($3.75) ($6.78) ($4.59) $0.00 ($1.95) ($0.56) ($5.91)
Adjusted Weighted Average Basic Shares Outstanding
1.14M 1.17M 1.21M 1.34M 1.50M 1.76M 1.85M 0.00 4.01M 11.15M 58.30M
Adjusted Diluted Earnings per Share
$0.65 ($2.35) ($1.15) $0.10 ($3.75) ($6.78) ($4.59) $0.00 ($1.95) ($0.56) ($5.91)
Adjusted Weighted Average Diluted Shares Outstanding
1.16M 1.17M 1.24M 1.18M 1.69M 1.76M 1.85M 0.00 4.44M 11.15M 58.30M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
1.16M 1.18M 1.33M 1.18M 1.69M 1.99M 2.40M 0.00 0.00 16.08M 0.00
Normalized Net Operating Profit after Tax (NOPAT)
1.34 -2.87 0.78 -0.16 -4.27 -8.70 -6.30 -2.20 -3.32 -9.69 -16
Normalized NOPAT Margin
1.03% -2.57% 1.94% -0.39% -11.60% -24.79% -18.59% 0.00% 0.00% -40.77% -64.39%
Pre Tax Income Margin
1.15% -5.05% -0.10% 9.79% -17.22% -43.20% -26.35% 0.00% 0.00% -71.18% -1,723.95%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
2.52 -3.37 0.97 5.55 -8.48 -9.24 -16.71 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
1.35 -2.22 0.67 -0.34 -6.39 -5.88 -12.49 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
1.71 -3.68 0.64 13.11 -9.00 -9.39 -17.71 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.54 -2.53 0.35 7.22 -6.90 -6.02 -13.50 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for ALT5 Sigma

This table displays calculated financial ratios and metrics derived from ALT5 Sigma's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/30/2023 3/30/2024 6/29/2024 9/28/2024 12/28/2024 3/29/2025 6/28/2025 9/27/2025 12/27/2025 3/28/2026
DEI Shares Outstanding
3,768,878.00 4,957,647.00 4,957,647.00 8,976,379.00 12,769,015.00 14,069,469.00 16,078,647.00 17,454,660.00 122,609,376.00 122,609,376.00 126,199,169.00
DEI Adjusted Shares Outstanding
3,768,878.00 4,957,647.00 4,957,647.00 8,976,379.00 12,769,015.00 14,069,469.00 16,078,647.00 17,454,660.00 122,609,376.00 122,609,376.00 126,199,169.00
DEI Earnings Per Adjusted Shares Outstanding
-0.06 -3.59 -0.43 0.07 -0.06 -0.91 -0.12 -0.52 0.40 -3.10 -2.15
Growth Metrics
- - - - - - - - - - -
Revenue Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 194.05% 53.31% -67.76% -2.83%
EBITDA Growth
-243.01% -575.28% -32.80% -3,841.67% 16.62% 45.39% 121.23% -119.06% 11,075.52% -5,110.58% -125,939.72%
EBIT Growth
-431.09% -857.51% -44.21% -488.78% -7.61% 42.92% 50.84% -201.79% 5,500.98% -4,789.15% -36,703.52%
NOPAT Growth
12.47% -800.16% -64.33% -26.15% 4.19% 47.56% -7.75% 13.93% -2,463.73% 76.93% -40.96%
Net Income Growth
89.20% -716.55% -121.26% 378.86% -284.11% 28.34% -11.57% -1,647.54% 6,056.45% -2,879.80% -11,250.04%
EPS Growth
92.06% -519.83% -110.79% 133.33% -20.00% 79.72% 55.88% -800.00% 583.33% -436.89% -1,326.67%
Operating Cash Flow Growth
88.69% 38.59% -122.42% 169.57% 1,055.13% -377.26% -161.58% -6,580.00% -308.42% 525.67% -763.88%
Free Cash Flow Firm Growth
-1,001.76% 0.00% 152.56% 82.91% 105.73% -124.70% -242.09% -29.04% -119,997.68% -43,011.16% -3,306.16%
Invested Capital Growth
340.37% -66.07% -69.26% 11.21% -6.34% -30.55% 282.93% 15.38% 5,755.50% 14,209.08% 2,653.43%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% 127.80% 237.26% -70.90% 31.53% 18.77% -29.07% -12.30%
EBITDA Q/Q Growth
-1,203.33% -2,425.68% 92.06% -69.05% 75.41% -1,554.17% 103.09% -1,843.97% 1,331.90% -885.31% 25.41%
EBIT Q/Q Growth
-238.28% -1,566.54% 88.49% 9.30% 38.17% -783.95% 90.08% -456.77% 1,206.48% -900.18% 25.34%
NOPAT Q/Q Growth
60.40% -2,115.05% 89.33% -34.77% 69.93% -1,112.30% 78.07% -7.66% -795.77% 89.09% -34.00%
Net Income Q/Q Growth
-273.98% -8,220.56% 87.96% 127.47% -239.56% -1,452.19% 81.25% -281.06% 637.16% -876.51% 28.59%
EPS Q/Q Growth
-266.67% -10,060.00% 93.31% 120.59% -185.71% -1,616.67% 85.44% -226.67% 159.18% -2,006.90% 61.30%
Operating Cash Flow Q/Q Growth
-281.74% 6.83% -33.01% 114.71% 5,141.25% -146.55% 27.10% -264.30% -68.58% 195.08% -247.95%
Free Cash Flow Firm Q/Q Growth
20.34% 147.99% 65.74% -126.97% 126.69% -306.96% -853.44% 75.50% -24,702.69% 25.58% 24.67%
Invested Capital Q/Q Growth
2.09% -59.05% -26.91% 263.97% -14.02% -69.64% 303.00% 9.67% 4,263.43% -25.80% -22.45%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
0.00% 0.00% 0.00% 50.62% 47.78% 47.04% 39.72% 43.51% 34.63% 40.93% 75.85%
EBITDA Margin
0.00% 0.00% 0.00% -103.50% -11.17% -54.79% 5.82% -77.11% 799.80% -8,854.98% -7,531.15%
Operating Margin
0.00% 0.00% 0.00% -112.22% -14.81% -53.25% -40.13% -32.85% -218.34% -38.10% -58.21%
EBIT Margin
0.00% 0.00% 0.00% -82.25% -22.32% -58.51% -19.94% -84.42% 786.44% -8,871.99% -7,552.84%
Profit (Net Income) Margin
0.00% 0.00% 0.00% 27.16% -16.64% -76.57% -49.33% -142.91% 646.36% -7,075.99% -5,761.74%
Tax Burden Percent
80.15% 108.37% 96.62% -33.09% 96.71% 105.68% 141.79% 153.61% 83.36% 79.46% 76.18%
Interest Burden Percent
26.05% 96.18% 112.81% 99.78% 77.06% 123.83% 174.46% 110.22% 98.59% 100.37% 100.14%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 20.57% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% -5.81% -2.68% -90.03% -39.21% -15.37% -5.45% -1.14% -2.17%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 119.08% -36.82% 24.13% -89.36% -247.57% -8,329.65% 4,593.23% -34,763.34%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 7.95% -1.26% -8.88% -9.95% -27.19% 7.85% -64.23% -58.21%
Return on Equity (ROE)
88.82% -55.76% -112.14% 2.14% -3.94% -98.91% -49.16% -42.57% 2.39% -65.37% -60.38%
Cash Return on Invested Capital (CROIC)
-145.29% 38.09% 26.28% -62.91% -49.24% -62.41% -164.92% -30.24% -195.46% -199.98% -189.55%
Operating Return on Assets (OROA)
0.00% 0.00% 0.00% -3.26% -2.90% -29.53% -11.82% -22.09% 22.83% -340.31% -359.59%
Return on Assets (ROA)
0.00% 0.00% 0.00% 1.07% -2.16% -38.64% -29.24% -37.40% 18.76% -271.42% -274.32%
Return on Common Equity (ROCE)
44.39% 1.99% -29.30% 0.78% -1.35% 3.04% 0.34% -10.69% 2.32% -63.46% -57.63%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-0.53 -12 -1.26 -1.70 -0.51 -6.21 -1.36 -1.47 -13 -1.43 -1.92
NOPAT Margin
0.00% 0.00% 0.00% -78.55% -10.37% -37.28% -28.09% -22.99% -173.42% -26.67% -40.75%
Net Nonoperating Expense Percent (NNEP)
-11.05% 66.80% 471.74% -124.88% 34.13% -114.16% 50.15% 232.19% 8,324.20% -4,594.37% 34,761.17%
Return On Investment Capital (ROIC_SIMPLE)
-3.69% 455.44% -25.92% -5.12% -1.63% -21.11% -3.45% -2.83% -0.83% -0.12% -0.21%
Cost of Revenue to Revenue
0.00% 0.00% 0.00% 49.38% 52.22% 52.96% 60.28% 56.49% 65.37% 59.07% 24.15%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 162.84% 62.60% 100.29% 79.85% 76.36% 252.96% 79.02% 134.06%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
0.00% 0.00% 0.00% 162.84% 62.60% 100.29% 79.85% 76.36% 252.96% 79.02% 134.06%
Earnings before Interest and Taxes (EBIT)
-1.03 -17 -1.97 -1.78 -1.10 -9.75 -0.97 -5.38 60 -477 -356
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-0.66 -17 -1.33 -2.25 -0.55 -9.13 0.28 -4.92 61 -476 -355
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.11 0.00 0.00 3.15 6.28 26.63 16.75 16.34 0.25 0.13 0.18
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.25 0.13 0.18
Price to Revenue (P/Rev)
0.00 0.00 0.00 9.27 3.25 2.63 2.32 6.38 15.27 5.82 6.28
Price to Earnings (P/E)
0.12 0.00 0.00 0.00 0.00 0.00 0.00 0.00 11.48 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
829.61% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 8.71% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.54 1.52 3.04 1.45 1.73 10.70 2.92 5.03 0.27 0.15 0.21
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 20.60 6.48 3.63 3.32 8.06 16.67 6.86 7.48
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 7.65 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 8.51 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
12.79 12.08 0.00 0.00 13.87 48.60 105.79 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 2.02 5.44 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.06 0.14 0.38 0.46 0.67 0.48 0.68 0.01 0.01 0.03
Long-Term Debt to Equity
0.00 0.06 0.07 0.16 0.30 0.60 0.32 0.52 0.01 0.01 0.03
Financial Leverage
0.20 0.64 0.01 0.07 0.03 -0.37 0.11 0.11 0.00 -0.01 0.00
Leverage Ratio
2.21 2.33 1.50 1.99 2.06 3.02 2.62 2.84 1.08 1.10 1.12
Compound Leverage Factor
0.58 2.24 1.69 1.99 1.59 3.74 4.57 3.13 1.07 1.10 1.12
Debt to Total Capital
0.00% 5.94% 12.58% 27.78% 31.63% 40.05% 32.61% 40.55% 1.12% 1.30% 3.07%
Short-Term Debt to Total Capital
0.00% 0.00% 6.84% 15.98% 11.16% 4.13% 10.89% 9.58% 0.57% 0.55% 0.53%
Long-Term Debt to Total Capital
0.00% 5.94% 5.74% 11.80% 20.47% 35.92% 21.72% 30.96% 0.55% 0.74% 2.53%
Preferred Equity to Total Capital
0.00% 0.00% 91.07% 44.54% 46.89% 30.34% 41.19% 31.14% 1.10% 0.80% 1.02%
Noncontrolling Interests to Total Capital
50.02% 121.84% 44.43% 10.50% 11.05% 22.55% 17.06% 12.73% 0.45% 0.63% 0.79%
Common Equity to Total Capital
49.98% -27.78% -48.08% 17.19% 10.43% 7.06% 9.14% 15.58% 97.33% 97.27% 95.12%
Debt to EBITDA
0.00 -0.04 -0.06 -0.49 -0.54 -1.01 -1.21 -3.26 0.33 -0.04 -0.04
Net Debt to EBITDA
0.00 -0.02 -0.05 -0.20 -0.12 -0.46 -0.29 -1.88 0.19 -0.02 -0.02
Long-Term Debt to EBITDA
0.00 -0.04 -0.03 -0.21 -0.35 -0.90 -0.81 -2.49 0.16 -0.02 -0.03
Debt to NOPAT
0.00 -0.05 -0.08 -0.67 -0.73 -1.38 -1.44 -4.26 -1.03 -0.95 -1.71
Net Debt to NOPAT
0.00 -0.03 -0.06 -0.27 -0.16 -0.64 -0.34 -2.46 -0.60 -0.56 -0.78
Long-Term Debt to NOPAT
0.00 -0.05 -0.04 -0.29 -0.47 -1.23 -0.96 -3.25 -0.50 -0.55 -1.42
Altman Z-Score
-1.33 -7.02 -4.06 -0.96 -0.84 -0.62 -0.03 0.35 2.96 -0.31 -0.70
Noncontrolling Interest Sharing Ratio
50.02% 103.57% 73.87% 63.52% 65.79% 103.07% 100.69% 74.88% 2.84% 2.92% 4.54%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.21 0.06 0.15 0.73 0.75 0.84 0.83 0.88 0.79 0.57 0.82
Quick Ratio
0.17 0.05 0.05 0.16 0.23 0.18 0.42 0.40 0.15 0.17 0.43
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-22 11 18 -4.82 1.29 -2.66 -25 -6.22 -1,543 -1,148 -865
Operating Cash Flow to CapEx
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.00 0.00 0.00 0.04 0.13 0.50 0.59 0.26 0.03 0.04 0.05
Accounts Receivable Turnover
0.00 0.00 0.00 4.34 15.42 79.78 10.41 6.51 26.13 18.95 7.58
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 37.37 41.52 0.00 41.31
Accounts Payable Turnover
0.00 0.00 0.00 0.37 1.36 4.54 4.12 3.29 4.08 3.52 4.18
Days Sales Outstanding (DSO)
0.00 0.00 0.00 84.06 23.67 4.58 35.05 56.07 13.97 19.26 48.12
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 994.12 269.08 80.48 88.60 110.86 89.40 103.78 87.33
Cash Conversion Cycle (CCC)
0.00 0.00 0.00 -910.07 -245.41 -75.91 -53.55 -54.79 -75.43 -84.52 -39.20
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
28 12 8.49 31 27 8.07 33 36 1,556 1,155 895
Invested Capital Turnover
0.00 0.00 0.00 0.07 0.26 2.42 1.40 0.67 0.03 0.04 0.05
Increase / (Decrease) in Invested Capital
22 -23 -19 3.12 -1.80 -3.55 24 4.75 1,529 1,147 863
Enterprise Value (EV)
15 18 26 45 46 86 95 179 415 171 185
Market Capitalization
1.55 2.75 13 20 23 63 66 142 380 145 155
Book Value per Share
$3.85 ($0.67) ($0.85) $0.71 $0.29 $0.17 $0.25 $0.50 $12.52 $9.32 $6.94
Tangible Book Value per Share
($0.98) ($4.27) ($4.32) ($4.05) ($2.98) ($1.44) ($2.55) ($2.08) $12.16 $9.03 $6.67
Total Capital
29 12 8.78 37 35 33 43 56 1,578 1,174 925
Total Debt
0.00 0.71 1.10 10 11 13 14 23 18 15 28
Total Long-Term Debt
0.00 0.71 0.50 4.38 7.22 12 9.42 17 8.66 8.75 23
Net Debt
-0.64 0.42 0.86 4.12 2.49 6.16 3.33 13 10 9.03 13
Capital Expenditures (CapEx)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.01 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-2.40 -5.56 -6.35 -11 -15 -12 -12 -8.74 -9.87 -22 -17
Debt-free Net Working Capital (DFNWC)
-1.99 -5.56 -6.28 -5.69 -6.49 -5.16 -1.68 0.82 -2.56 -15 -1.93
Net Working Capital (NWC)
-1.99 -5.56 -6.88 -12 -10 -6.54 -6.40 -4.52 -12 -22 -6.88
Net Nonoperating Expense (NNE)
-0.32 5.96 0.88 -2.29 0.31 6.55 1.03 7.65 -62 379 270
Net Nonoperating Obligations (NNO)
-0.64 0.42 0.82 4.08 2.45 -12 3.29 2.51 -3.94 -4.60 -1.74
Total Depreciation and Amortization (D&A)
0.36 0.36 0.64 -0.46 0.55 0.62 1.25 0.47 1.01 0.91 1.02
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 0.00% 0.00% -528.08% -213.25% -51.91% -43.63% -39.28% -39.67% -87.15% -70.66%
Debt-free Net Working Capital to Revenue
0.00% 0.00% 0.00% -262.33% -91.32% -21.72% -5.86% 3.68% -10.27% -62.10% -7.83%
Net Working Capital to Revenue
0.00% 0.00% 0.00% -536.01% -146.71% -27.50% -22.36% -20.33% -46.56% -88.30% -27.84%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.05) ($5.08) ($0.34) $0.07 ($0.06) ($1.03) ($0.18) ($0.49) $0.67 ($5.91) ($2.14)
Adjusted Weighted Average Basic Shares Outstanding
4.20M 4.01M 6.31M 8.40M 12.81M 11.20M 15.55M 18.55M 72.89M 58.30M 126.82M
Adjusted Diluted Earnings per Share
($0.05) ($5.08) ($0.34) $0.07 ($0.06) ($1.03) ($0.18) ($0.49) $0.29 ($5.53) ($2.14)
Adjusted Weighted Average Diluted Shares Outstanding
4.20M 4.44M 6.31M 8.40M 12.81M 11.20M 15.55M 18.55M 168.66M 58.30M 126.82M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
4.96M 0.00 8.98M 12.77M 14.07M 16.08M 17.45M 122.61M 0.00 0.00 139.84M
Normalized Net Operating Profit after Tax (NOPAT)
-0.53 -12 -1.26 -1.70 -0.51 -6.21 -1.36 -1.47 -13 -1.43 -1.92
Normalized NOPAT Margin
0.00% 0.00% 0.00% -78.55% -10.37% -37.28% -28.09% -22.99% -173.42% -26.67% -40.75%
Pre Tax Income Margin
0.00% 0.00% 0.00% -82.07% -17.20% -72.45% -34.79% -93.04% 775.37% -8,904.75% -7,563.58%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

ALT5 Sigma Corp (NASDAQ: ALTS) showed a sharp deterioration in operating performance in Q1 2026, with revenue down sequentially but losses widening dramatically due to a very large non-operating charge.

For the quarter ended March 28, 2026, the company reported $4.7 million in revenue, down from $5.4 million in Q4 2025 and well below the more volatile revenue levels seen in prior periods. Gross profit was $3.6 million, but SG&A expenses were still $6.3 million, leaving an operating loss of $2.7 million.

The biggest issue in the quarter was a massive $353.1 million other expense, which drove pre-tax loss to $356.4 million and net loss to $271.5 million. That compares with a much smaller net loss of $380.2 million in Q4 2025, but the comparison is distorted by unusual items and large accounting adjustments. On the cash flow statement, the company still posted negative operating cash flow of $12.3 million, although financing inflows and foreign exchange effects helped it end the quarter with a $4.3 million increase in cash.

Looking over the last several quarters, ALT5 Sigma has shown highly inconsistent profitability, cash flow, and balance sheet trends. The company’s balance sheet is much larger than a year ago, but a large portion of that growth appears tied to noncurrent assets and financing activity rather than consistent organic earnings power.

  • Cash and equivalents improved quarter over quarter, rising to $10.5 million in Q1 2026 from $7.3 million in Q3 2025.
  • Total equity remains large on paper, with $893.2 million in total equity and noncontrolling interests at Q1 2026.
  • Revenue was still positive at $4.7 million in Q1 2026, showing the business continues to generate sales.
  • Gross profit stayed positive at $3.6 million, indicating the core revenue base still has contribution margin.
  • Debt levels are manageable relative to the balance sheet, with $28.4 million in total debt at Q1 2026.
  • Investing cash flow was flat in Q1 2026, which may indicate limited capital spending but also limited visible reinvestment.
  • Exchange-rate movements had a material impact on reported cash flow, adding $8.1 million in Q1 2026.
  • Balance sheet growth is concentrated in noncurrent assets, especially other noncurrent operating assets of $706.5 million, which deserves scrutiny from investors.
  • Operating cash flow was negative at -$12.3 million in Q1 2026, suggesting the business is not yet self-funding.
  • The quarter included a massive other expense of $353.1 million, which drove the majority of the reported net loss.

Trend summary: ALT5 Sigma’s recent history shows a company that can generate revenue and gross profit, but it has struggled to convert that into steady earnings or operating cash flow. Revenue has been volatile, operating expenses remain high, and the company has relied heavily on financing and accounting adjustments. Investors should pay close attention to whether the large noncurrent assets and the outsized other expense are one-time items or signs of deeper balance sheet and earnings quality issues.

07/16/26 11:19 PM ETAI Generated. May Contain Errors.

ALT5 Sigma Financials - Frequently Asked Questions

According to the most recent income statement we have on file, ALT5 Sigma's fiscal year ends in December. Their fiscal year 2025 ended on December 27, 2025.

ALT5 Sigma's net income appears to be on an upward trend, with a most recent value of -$343.21 million in 2025, falling from $795 thousand in 2014. The previous period was -$15.14 million in 2024. Check out ALT5 Sigma's forecast to explore projected trends and price targets.

ALT5 Sigma's total operating income in 2025 was -$22.85 million, based on the following breakdown:
  • Total Gross Profit: $10.19 million
  • Total Operating Expenses: $33.04 million

Over the last 10 years, ALT5 Sigma's total revenue changed from $130.93 million in 2014 to $24.84 million in 2025, a change of -81.0%.

ALT5 Sigma's total liabilities were at $60.25 million at the end of 2025, a 8.0% increase from 2024, and a 91.7% increase since 2014.

In the past 10 years, ALT5 Sigma's cash and equivalents has ranged from $5 thousand in 2023 to $7.18 million in 2024, and is currently $6.22 million as of their latest financial filing in 2025.

Over the last 10 years, ALT5 Sigma's book value per share changed from 2.35 in 2014 to 9.32 in 2025, a change of 296.5%.



Financial statements for NASDAQ:AIFC last updated on 7/16/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners